Walleye Capital
NAMSW icon

Walleye Capital’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Walleye Capital’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,658
Closed -$70.9K – 5723
2023
Q4 		$70.9K Hold
22,658
– – ﹤0.01% 4189
2023
Q3 		$43K Sell
22,658
-9,600
-30% -$18.6K ﹤0.01% 4230
2023
Q2 		$67.4K Buy
32,258
+6,272
+24% +$13.5K ﹤0.01% 3559
2023
Q1 		$47.8K Sell
25,986
-2,402
-8% -$3.81K ﹤0.01% 3216
2022
Q4 		$24.6K Buy
+28,388
New +$23.4K ﹤0.01% 2632

Other funds holding NAMSW

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

Walleye Capital's NAMSW Position: Q1 2024 in Review

Walleye Capital sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q1 2024, closing a stake of 22,658 shares — an estimated $70.9K sold.

Walleye Capital first reported a position in NAMSW in Q4 2022 and held it in 5 quarters. The position peaked at $70.9K in Q4 2023. 11 funds tracked by Wall St. Rank hold NAMSW as of Q1 2024.

  • Walleye Capital reported no remaining NewAmsterdam Pharma Warrant position as of Q1 2024 after selling out during the quarter.
  • Walleye Capital sold 22,658 NewAmsterdam Pharma Warrant shares in Q1 2024, an estimated $70.9K.
  • Walleye Capital first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 5 quarters.
  • Walleye Capital's NewAmsterdam Pharma Warrant position peaked at $70.9K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2024.

Based on Walleye Capital's 13F filing for Q1 2024, filed 15 May 2024.